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1. An initial diagnosis of respiratory sepsis (pneu-
monia and/or empyma) was made, but the ser-
ohemorrhagic nature of the pleural effusion led to
the clinical suspicion of active hemorrhage into the
pleural cavity. When the CT scan of the thorax was
performed, it showed a sacular aneurysm of the
descending aorta with perianeurysmal hematoma
and a massive hemorrhagic effusion with areas of
different density in the pleural cavity. A few min-
utes later, the patient died in cardiovascular col-
lapse, before surgical intervention was possible.
Autopsy was not authorized. Salmonella enteritidis
serotype D was isolated from blood and in pleural
fluid cultures.
The patient thus had a sacular mycotic aneurysm
of the descending aorta which ruptured towards
the pleural cavity, caused by S. enteritidis. Mycotic
aneurysms (MAs) caused by Salmonella species
have often been described, because of the propen-
sity of this microorganism to infect vascular sites.
Salmonella. enteritidis serotypes are the most fre-
quently reported in Europe, e.g. in Spain [1],
whereas S. cholerasuis and S. typhimurium are pre-
dominant in the USA [2]. Merkin et al. found only
14 cases of thoracic aortic aneurysms produced by
Salmonella species in their study of cases recorded
from 1950 to 1993, and S. enteritidis serotype D was
the most frequent [3]. Any Salmonella serotype can
produce bacteremia, and Cohen et al. reported that
25% of people over 50 years with salmonella bac-
teremia had endothelial infection, demonstrating
the important role played by this microorganism
in the pathogenesis of intravascular infections [4].
Nevertheless, reported cases of mycotic aneur-
ysms caused by Salmonella are scarce, and the
intrathoracic location in this case is exceptional.
2. A high index of suspicion is essential if the diag-
nosis of mycotic aneurysm is to be made, because
initial symptoms are frequently non-specific and
earlydiagnosis is important forpromptandsuccess-
ful treatment [5]. The diagnosis can be established
when there are appropriate clinical findings, such
as high fever and chills, or symptoms related to the
location of the aneurysm (back, shoulder or abdo-
minal pain), along with recurrent bacteremia and
the demonstration of aneurysmal dilatation of the
aortic wall on a CT scan of the thorax. This last
finding should be confirmed by aortography. Fin-
ally, the presence of cardiovascular risk factors or
established arteriosclerotic disease also supports
the diagnosis. Probably, the patient had repeated
ruptures, coinciding with bacteremia, that were
contained by perianeurysmal inflammatory activ-
ity. Such presumed intermittent bleeding areas
explain the finding of areas of different density
in the pleural cavity. Cases of relapsing rupture,
contained by the blood itself or by other structures
such as the parietal pleura, mediastinum or retro-
peritoneum, have also been described [6,7].
3. The optimal treatment is surgical debridement
of the aneurysm and the restoration of arterial flow
by prosthetic reconstruction in situ or by extra-
anatomic bypass [8]. Prolonged administration of
antibiotics is required, usually for more than
6 weeks, and several authors recommend lifelong
antimicrobial therapy because of high relapse
rates. However, despite early surgical interven-
tion, development of new surgical techniques,
and effective bactericidal antibiotics such as ampi-
cillin, ciprofloxacin, or third-generation cephalos-
porins, the mortality rate in these patients remains
as high as 75% [3,8–10]. Finally, although salmo-
nella gastroenteritis is usually a self-limiting dis-
ease, and bacteremia develops in less than 5% of all
patients, certain individuals are at increased risk of
invasive infection, and may benefit from preven-
tive antimicrobial therapy. Antimicrobial therapy
should be considered for neonates, persons older
than 50 years, and patients with immunosuppres-
sion, cardiac valvular or mural abnormalities, or
prosthetic vascular grafts.
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